4 Healthcare Stocks Rising More Than 50% in 2024 With Room to Grow

Industry Overview - The healthcare sector is facing persistent inflationary challenges, leading to increased healthcare costs that adversely affect performance [1][14] - Health insurers are responding by designing affordable health plans and expanding into underserved U.S. communities, which supports membership growth and increases premiums [2] - The aging U.S. population is expected to sustain robust demand for Medicare plans in 2025 [2] - There is a growing need for specialized rehabilitative care, driving revenue growth for inpatient rehabilitation services and behavioral health facilities [3] - The medical device industry is encountering significant challenges due to regulatory hurdles, supply-chain disruptions, and geopolitical tensions, which have been exacerbated by inflation [4] - Healthcare companies are heavily investing in telehealth services, which are expected to generate consistent revenue streams in the long term despite initial costs [5] Company Highlights - Doximity, Inc. is leveraging strategic acquisitions and AI-powered solutions to enhance service offerings, positioning itself as a preferred partner for healthcare organizations [7] - Boston Scientific Corporation is benefiting from international expansion and innovative technologies, with strong market share gains and strategic acquisitions bolstering its position [8] - LeMaitre Vascular is capitalizing on the demand for vascular medical devices driven by an aging population and chronic diseases, supported by strategic acquisitions and R&D investments [9] - Globus Medical is expanding its market share in musculoskeletal solutions through innovative products and a merger with NuVasive, positioning itself for continued success [10] Financial Performance - Doximity's fiscal 2025 earnings estimate is $1.14 per share, indicating a 20% year-over-year growth, with shares surging 107.5% year to date [18] - Boston Scientific's 2024 earnings estimate is $2.46 per share, reflecting a 20% year-over-year improvement, with shares gaining 55.4% year to date [20] - LeMaitre Vascular's 2024 earnings estimate is $1.94 per share, indicating 43.7% year-over-year growth, with shares increasing by 61% year to date [22] - Globus Medical's 2024 earnings estimate is $2.97 per share, showing a 28% year-over-year improvement, with shares gaining 55.9% year to date [24]